▮ Entertainment

Top Stories
Slide Shows
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ More

Wall Street Events

Plus

Neg

Email

Cintas Q2 20 Earnings Conference Call At 5:00 PM ET

By RTTNews Staff Writer ✉ | Published: 12/17/2019 6:06 AM ET

Cintas Corporation (CTAS) will host a conference call at 5:00 PM ET on December 17, 2019, to discuss Q2 20 earnings results.

To access the live webcast, log on to www.Cintas.com

For comments and feedback contact: editorial@rttnews.com

PDUFA Biotech stocks Chemotherapy COVID19 vaccines heart failure lupus ARS

Biotech Stocks Facing FDA Decision In January 2021

New Drugs Approved In November

New Drugs Approved In November

PDUFA 2020 Multiple Sclerosis Cystic Fibrosis Edema PAH Sleep wake disorder hereditary angioedema attacks

Biotech Stocks Facing FDA Decision In December 2020

Latest Updates on COVID-19

COVID-19 Deaths Up By At Least 10% In 25 US States

Johnson & Johnson's Covid-19 Vaccine Safe, Well-tolerated

Switzerland Authorizes Moderna's COVID-19 Vaccine

Vir, GSK In Deal With NHS-Supported AGILE To Evaluate VIR-7832 In Early Treatment Of COVID-19

COVID Hospitalizations Dropping In US For 4th Straight Day

Read More

COVID-19: Drugs in Development

RELATED NEWS

Cintas Corporation Q2 Profit Advances

Cintas Q2 21 Earnings Conference Call At 10:00 AM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

Lake Champlain Recalls Milk Chocolate Products

Health Alert Issued For Beef Jerky Products

GE Sues Siemens Energy For Allegedly Stealing Gas-Turbine Trade Secrets

Cigarette Health Warnings Effective Date Postponed

JPMorgan Chase & Co Q4 Profit Tops Estimates; Managed Net Revenue Up 3%

Scalpa Numb Maximum Strength Topical Anesthetic Cream Being Recalled

WOOF! Petco Soars In First Day Trading

US' NHTSA Asks Tesla To Recall 158000 Vehicles

Restaurant Trends In 2021

Travelers To U.S Required To Show Evidence Of Negative COVID-19 Test: American Airlines

Sea To Summit Recalls Camping Pots For Burn, Scald Risks

Johnson & Johnson's Covid-19 Vaccine Safe, Well-tolerated

Stock Alert: Marinus Pharmaceuticals Climbs 11%

Johnson & Johnson's Covid-19 Vaccine Safe, Well-tolerated

Pre-market Movers In Healthcare Sector: DBVT, OBSV, APYX...

FDA Conditionally Approves First Oral Tablet Laverdia-CA1 To Treat Dogs With Lymphoma

Will 2021 Continue To Be An Exciting Year For Relmada Therapeutics?

Pre-market Movers In Healthcare Sector: ORGO, NK, APYX, BIOL, ATHE, ACER…

FDA Expands Approved Use Of PFE's Xalkori, LXRX Soars On Sotagliflozin Update, BCYC Hits New High

US' NHTSA Asks Tesla To Recall 158000 Vehicles

Stock Alert: Lexicon Pharmaceuticals Surges 35%

FDA Grants EUA To PerkinElmer's SARS-CoV-2 RT-PCR Assay For Asymptomatic Testing - Quick Facts

Stock Alert: Lemonade Rises 8%

FDA Grants Hoth Pre-IND Meeting On Proposed Drug Development Plan For HT-001 Treatment

CES 2021 To Feature More Than 1900 Exhibitors

EU Conditionally Approves LSE's $27 Bln Acquisition Of Refinitiv

New Fortress To Acquire Hygo Energy, Golar LNG In Combined $5 Bln Deal - Quick Facts

Qualcomm Technologies To Acquire NUVIA - Quick Facts

Tesla Registers Its Indian Entity

Danaher Boosts Q4 Revenue Growth Outlook - Quick Facts

Linde To Build And Operate PEM Electrolyzer For Green Hydrogen

Kenmare Resources Says Achieved Or Exceeded Midpoint Of Finished Products Guidance Ranges

Howden Joinery Says Trading Stronger Than Anticipated; Lifts FY20 Pre-tax Profit View

QinetiQ Says It Continues Strong Performance Through Q3

Big Yellow Q3 Revenue Rises; Sees Growth In Q4, Confident Of Longer-term Growth

Nordex Wins Order For 518 MW Wind Farm Project From Statkraft In Brazil